ROSENWALD LINDSAY A MD (PRESIDENT AND CEO) purchased 26.4% of their position (763.36K shares) of FORTRESS BIOTECH, INC. on the open market
Open‑market purchase worth $1.40M — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/25/2024ACC: 0001415889-24-023957
DirectorOfficer10% Owner· PRESIDENT AND CEO
Since Jan 2018
+1.53M
Net shares
Net buyer
$1.40M
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
1.53M acquired
Non-Derivative Transactions1
Common stock, par value $0.001
Direct
Shares
+763.36K
Price / share
$1.84
Trade value
$1.40M
% of position
26.4%
9/23/2024
2.89M→3.66M
Total
Net shares
+763.36K
Net value
$1.40M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 Direct | 9/23/2024 | P · Purchase | +763.36K | $1.84 | $1.40M | 26.4% | 2.89M | 3.66M |
| Total | +763.36K | $1.40M | ||||||
Derivative Transactions1
Warrants to Purchase Common Stock
Direct
Converts to
Common Stock
763.36K shares
Shares
+763.36K
Strike price
1.84
Held after
763.36K
Exercisable
—
9/23/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants to Purchase Common Stock Direct | Common Stock763.36K shares | 9/23/2024 | P · Purchase | +763.36K | 1.84 | — | 763.36K |